Salsalate shows efficacy as add-on treatment in diabetes

07/2/2013 | InternalMedicineNews.com (free registration)

Research on patients with poorly controlled type 2 diabetes revealed those who used oral salsalate as an add-on to one to three diabetes drugs attained lower A1C rates at 48 weeks than those in the placebo group. Data also showed 41% of those in the salsalate group attained 0.5 percentage points or greater reductions in A1C at the study's conclusion, compared with 23% of those who took a placebo. The findings appear in the Annals of Internal Medicine.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX